Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR XR and Spatial Computing (JMXR) (no longer under consideration since Sep 03, 2026)

Date Submitted: Aug 25, 2025
Open Peer Review Period: Dec 16, 2025 - Feb 10, 2026
(closed for review but you can still tweet)

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Receptivity of Black Men to a Point of Prostate Cancer Diagnosis Virtual Reality Assistant (ViRA)

  • Folakemi T. Odedina; 
  • Che Ngufor; 
  • Dottington Fulllwood; 
  • Mary Ellen Young; 
  • Deidre Pereira; 
  • Christopher Williams; 
  • Vinessa Gordon; 
  • Dee Glaser-Boivin; 
  • Jada Melton; 
  • Michelle Fudge; 
  • Arnold Merriweather; 
  • Motolani Adedipe; 
  • Opeyemi Bolajoko; 
  • Emanuel Agboola; 
  • Anthony Hill; 
  • John McCall; 
  • Inclusive Cancer Care Research Equity (iCCaRE) Consortium

ABSTRACT

Background:

Black men face a disproportionate burden of prostate cancer (CaP), compounded by unmet psychosocial needs at the point of prostate cancer diagnosis (PPCD). At the PPCD, many Black men experience profound emotional distress, uncertainty, and a lack of culturally competent care, which can negatively influence long-term survivorship and quality of life. To address these unmet needs, we developed a PPCD Virtual Reality Assistant (ViRA), an immersive, AI-powered intervention co-designed with Black prostate cancer survivors. The PPCD ViRA offers tailored psycho-oncology support, emotional guidance, and navigation of social determinants of health (SDOH), delivered through virtual reality environments.

Objective:

This study assessed the receptivity of Black men to the PPCD ViRA. Specifically, the primary objective was to establish the feasibility, acceptability, and usability of the Artificial Intelligent and augmented reality-based ViRA, designed to deliver psycho-oncology support, emotional reinforcement, and navigation of social determinants of health (SDOH) services.

Methods:

The PPCD ViRA was co-designed and co-developed with CaP survivors. Once developed, alpha testing was conducted to assess initial acceptability and usability of the ViRA among ten participants, including seven project team members and three Black CaP survivors.

Results:

Findings revealed high acceptability, strong emotional engagement, and clear potential to enhance the PPCD experience for Black men. Lessons learned highlight the importance of emotional timing, culturally embedded design, community co-creation, optional delivery formats, broader community partnerships, and inclusive implementation strategies in advancing digital health equity.

Conclusions:

Our findings support the feasibility and cultural acceptability of ViRA, while also identifying critical areas for refinement and larger-scale validation before clinical deployment. Clinical Trial: Not applicable.


 Citation

Please cite as:

Odedina FT, Ngufor C, Fulllwood D, Young ME, Pereira D, Williams C, Gordon V, Glaser-Boivin D, Melton J, Fudge M, Merriweather A, Adedipe M, Bolajoko O, Agboola E, Hill A, McCall J, Inclusive Cancer Care Research Equity (iCCaRE) Consortium

Receptivity of Black Men to a Point of Prostate Cancer Diagnosis Virtual Reality Assistant (ViRA)

JMIR Preprints. 25/08/2025:82976

DOI: 10.2196/preprints.82976

URL: https://preprints.jmir.org/preprint/82976

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.